News

Certa Honored in ProcureTech100 for AI-Driven Risk Management

Certa Honored in ProcureTech100 for AI-Driven Risk Management

Certa Recognized as a Leader in AI-Driven Risk Management

Certa, a prominent enterprise platform renowned for its capabilities in third-party risk, compliance, and ESG management, has been officially listed in the prestigious 2024 ProcureTech100. This recognition underscores Certa's commitment to innovation in digital procurement solutions. The ProcureTech100, a well-respected compilation established by ProcureTech in tandem with Kearney, showcases the most forward-thinking digital procurement tools available.

Highlights of the ProcureTech100 Selection

This year's selection process evaluated over 5,000 technological solutions through a rigorous series of assessments involving 80 global digital procurement authorities, industry experts, and financial investors. Solutions were assessed against fifteen distinct categories such as Innovation, Customer Satisfaction, and Advanced AI, ensuring that only the most relevant technologies were recognized.

Insights from Industry Experts

Dr. Elouise Epstein, Partner at Kearney, remarked on the ever-evolving landscape of procurement technology. She stated, "The procure tech space continues to be a powerful hub of innovation and inspiration. As we advance to the future, the market continues to grow and contract, which is a positive indicator of a dynamic ecosystem." This sentiment resonates strongly with Certa's commitment to leveraging technology to meet the challenges of the modern business landscape.

Innovative Generative AI Capabilities at Certa

Certa's inclusion in the ProcureTech100 not only highlights its technological advancements but also emphasizes the comprehensive generative AI capabilities embedded in its platform. By transforming unstructured data from contracts and reports, Certa enables organizations to derive actionable insights. Its innovative approach allows users to autofill questionnaires and streamline decision-making processes regarding third-party affiliations.

CEO's Vision for the Future

Jag Lamba, the CEO and Founder of Certa, expressed his enthusiasm about the platform's generative AI functionalities. He noted, "The ability to leverage artificial intelligence to analyze complex data signifies a fundamental shift in operational methodologies. Our technology transforms unstructured information into structured data, empowering organizations to make informed choices and efficiently manage their processes."

Key Features of Certa's Platform

The innovations within the Certa platform include:

  • AI-driven workflow design utilizing natural language.
  • Automated responses for questionnaires to simplify third-party onboarding.
  • Intelligent risk assessment leveraging various document types.
  • Plug-and-play ESG modules to ensure global compliance.
  • A redesigned user interface aimed at enhanced functionality.

Setting Industry Standards

Lance Younger, CEO of ProcureTech, acknowledged the challenges that organizations face in procurement. He stated, "The selected organizations in the 2024 ProcureTech100 are pioneers in the field, breaking through barriers for the industry and providing exceptional user experiences and scalability, solving both complex and simple procurement challenges." Certa's ongoing innovation reinforces its leadership within this dynamic ecosystem.

About Certa

Certa stands as the leading software platform that empowers enterprises to efficiently manage risks, compliance issues, and ESG assessments for their third-party relationships, encompassing vendors, partners, and clients. With over 130 integrations available, Certa's platform is designed to navigate the intricacies of regulations while ensuring strong, compliant, and sustainable third-party relationships.

About ProcureTech

ProcureTech is instrumental in accelerating the digital transformation in the procurement sector by addressing contemporary challenges through innovative strategies and solutions. Their collaborative efforts link procurement leaders, entrepreneurs, and the wider procuretech ecosystem for optimal results.

About Kearney

Kearney is a renowned global management consulting firm. With a workforce extending beyond 5,700 individuals across more than 40 nations, the firm collaborates with a significant portion of the Fortune Global 500 and other crucial global entities.

Frequently Asked Questions

What is the ProcureTech100?

The ProcureTech100 is an annual list that recognizes pioneering digital procurement solutions evaluated against multiple criteria for innovation and customer focus.

Why was Certa chosen for the ProcureTech100 list?

Certa was recognized for its advanced capabilities in third-party risk and compliance management, particularly its integration of generative AI technology.

What are the key features of Certa's platform?

Key features include AI-powered workflow design, automated questionnaire responses, intelligent risk assessment, and ESG compliance modules.

What trends are shaping the procure tech industry?

Current trends include the incorporation of artificial intelligence for data analysis, enhancing user experiences, and addressing complex procurement challenges dynamically.

How can companies benefit from using Certa's platform?

Organizations can streamline their third-party processes, make informed decisions, and ensure compliance while reducing the time and effort associated with manual processes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 214

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 295

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 282

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 92

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 143

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 86

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Oral Semaglutide Curbs Heavy Drinking: CU Study Insights

Updated Category News Views 12

New Frontiers in Tackling Alcohol Use Disorder Diabetes meds aren't just boxing in sugar levels; they're taking swings at alcohol cravings, too. The University of Colorado Anschutz threw their hat in the ring with a study that put oral semaglutide—usually in the diabetes and weight loss circuit—to a different test. Turns out, it's packing a punch against heavy...

Continue Reading
Julie Van Kleeck Strengthens Leadership at Paragon Space

Updated Category News Views 121

Julie Van Kleeck Joins Paragon Space Development Corporation Board Paragon Space Development Corporation (Paragon) proudly announces the appointment of Julie Van Kleeck to its Board of Directors. With a remarkable background in the space technology sector, Julie is set to enhance Paragon's mission with her extensive market insights and solid operational experience. Rich...

Continue Reading
Exploring Advanced Techniques for Fracture Healing in Orthopaedics

Updated Category News Views 302

Micromotion Nailing for Enhanced Fracture Healing OrthoXel is thrilled to announce an important presentation by Dr. Hannah Dailey, Co-Founder and Chief Scientific Officer, focusing on the innovative technique of micromotion nailing aimed at accelerating fracture healing. This presentation will be highlighted at an esteemed meeting gathering leading experts in the field of...

Continue Reading
Resilient Job Market Gains Amid Signs of Slowing Growth Ahead

Updated Category News Views 191

Overview of Recent Labor Market Trends The US economy has shown unexpected strength, adding more jobs than anticipated recently, instilling fresh optimism regarding the labor market's near-term stability. With political changes on the horizon, the economy's performance under the new administration remains a topic of interest. Nonetheless, we can assert that the incoming...

Continue Reading
MD Hyperbaric Expands Presence in Key U.S. Markets

Updated Category News Views 6

Expanding the Oxygen Therapy Frontier When you're talking about healing that's both ancient and cutting-edge, hyperbaric oxygen therapy (HBOT) kind of steals the show. MD Hyperbaric, calling the shots since 2021, is breaking new ground in San Antonio, Las Vegas, and Rochester. Why This Matters HBOT isn't just another fancy healthcare fad. We're seeing a real push toward...

Continue Reading